A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria

NCT00843388 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Nephropathy
Blood Pressure

Interventions

DRUG: Spironolacton (hexalacton(R))
DRUG: placebo tablet

Sponsor

Steno Diabetes Center Copenhagen